News
No drug is without potential side effects, and there are five major ones that people taking Ozempic, Wegovy or Mounjaro are ...
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that, amidst a ...
India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
17d
Pharmaceutical Technology on MSNNovo Nordisk’s CEO to step down as weight loss market share plummetsDespite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA asset tirzepatide, respectively sold under the brand names Zepbound and ...
13don MSN
Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...
Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results